U. Grohmann et al., IMMUNOGENIC PROPERTIES OF RETROVIRAL PROTEIN P15E FROM DRUG-TREATED MURINE MASTOCYTOMA P815, International journal of cancer, 55(2), 1993, pp. 344-350
A triazene-xenogenized tumor sub-line was derived from the mouse masto
cytoma cell line P81 5 following several transplant generations in viv
o on DTIC. The highly immunogenic P815/DTIC variant line expressed new
CTL-defined antigens. Novel antigens were also detected by antibodies
in immunoprecipitation and by Western blot analysis. Upon immunopreci
pitation of metabolically labeled cells, one such variant-specific 20-
kDa antigen was shown to be related to retroviral envelope protein p15
E. When injected intrasplenically into recipient mice, the electroblot
ted nitrocellulose-bound 20-kDa antigen resulted in increased frequenc
y in CTL precursors to P815/DTIC cells. In addition to previous data i
n the L5178Y/DTIC tumor-model system, these data suggest that expressi
on of aberrant, retrovirus-related proteins may be a common finding in
different parental tumors xenogenized by triazene treatment. (C) 1993
Wiley-Liss, Inc.